Centiva Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,888
Closed -$77.2K 1203
2022
Q4
$77.2K Buy
30,888
+16,888
+121% +$42.2K ﹤0.01% 813
2022
Q3
$59K Buy
+14,000
New +$59K ﹤0.01% 842
2021
Q3
Sell
-17,296
Closed -$268K 1068
2021
Q2
$268K Buy
+17,296
New +$268K 0.01% 789